You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Time to Progression

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Kidney Diseases Trial in Spain (Ambulatory blood pressure monitoring (ABPM), Home blood pressure monitoring (HBPM))

Recruiting
  • Chronic Kidney Diseases
  • Ambulatory blood pressure monitoring (ABPM)
  • Home blood pressure monitoring (HBPM)
  • La Estrada, Pontevedra, Spain
  • +7 more
May 16, 2022

Ovarian Cancer Trial in Toronto (Cediranib, Olaparib)

Completed
  • Ovarian Cancer
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 3, 2022

Bladder Cancer Trial (Second transurehral resection of bladder tumour)

Completed
  • Bladder Cancer
  • Second transurehral resection of bladder tumour
  • (no location specified)
Feb 23, 2021

COVID-19 Trial in South Africa (Molnupiravir 200 mg)

Recruiting
  • COVID-19
  • Molnupiravir 200 mg
  • Umtata, Eastern Cape, South Africa
  • +3 more
Aug 12, 2022

Metastatic Breast Cancer Trial in United States (Fulvestrant, erlotinib, Placebo)

Terminated
Has Results
  • Metastatic Breast Cancer
  • Jonesboro, Arkansas
  • +5 more
Mar 26, 2021

Anemia, Iron Deficiency, Hyperphosphatemia, Renal Insufficiency, Chronic Trial in United States (Ferric Citrate 1 GM Oral Tablet

Recruiting
  • Anemia, Iron Deficiency
  • +6 more
  • Ferric Citrate 1 GM Oral Tablet [AURYXIA]
  • Placebo
  • Pine Bluff, Arkansas
  • +22 more
Aug 15, 2022

Metastatic Gastric Cancer, Metastatic Adenocarcinoma of the Gastroesophageal Junction Trial in Worldwide (Ramucirumab)

No longer available
  • Metastatic Gastric Cancer
  • Metastatic Adenocarcinoma of the Gastroesophageal Junction
  • Ramucirumab
  • Graz, Austria
  • +43 more
Aug 17, 2022

Alzheimer's Disease Trial in Worldwide (LY3202626, Placebo)

Terminated
Has Results
  • Alzheimer's Disease
  • Irvine, California
  • +75 more
Mar 22, 2021

Glioblastoma Trial in Canada (PX-866)

Completed
Has Results
  • Glioblastoma
  • Calgary, Alberta, Canada
  • +6 more
May 7, 2020

EGFR Activating Mutation, Recurrent Non-Small Cell Lung Carcinoma, Stage IV NSCLC Trial in Winston-Salem (drug, biological,

Terminated
  • EGFR Activating Mutation
  • +2 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jan 28, 2021

Prostate Cancer Trial in Uppsala (No intervention)

Completed
  • Prostate Cancer
  • No intervention
  • Uppsala, Sweden
    Site SE46001
Jan 30, 2020

Genomic Landscape of EGFR Mutant NSCLC Prior to Erlotinib and at

Terminated
  • Carcinoma, Non-Small-Cell-Lung
  • +2 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jul 15, 2019

    Dose Dense Chemotherapy in Elderly Patients > 80 Years Old With

    Completed
    • DLBCL
    • Old Age; Debility
      • Homburg, Saarland, Germany
        Saarland University Medical Center
      Nov 20, 2023

      Myopia Trial in Australia, United States (Vivior)

      Not yet recruiting
      • Myopia
      • Vivior
      • Berkeley, California
      • +4 more
      Nov 3, 2023

      FDG-PET in Patients With FL at Time of Relapse/Progression

      Completed
      • Follicular Lymphoma
      • Metabolic activity measured by FDG-PET
      • Trani, BT, Italy
      • +26 more
      Feb 5, 2020

      NSCLC Trial (Cemiplimab)

      Recruiting
      • Non-small Cell Lung Cancer
      • Konstanz, Baden-Württemberg, Germany
      • +8 more
      Jan 6, 2023

      Prostatic Tumor, Adenocarcinoma, Tumor Recurrence Trial in Rennes, Pointe-à-Pitre (Standard care)

      Recruiting
      • Prostatic Neoplasm
      • +3 more
      • Standard care
      • Rennes, Ille-et-Vilaine, France
      • +1 more
      Sep 14, 2023

      Unfit CLL Included in GIMEMA LLC1114 Trial Who Discontinued

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • Observation
      • (no location specified)
      Oct 12, 2023

      Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Nanjing (6-month course of antiandrogen drugs, Long-term course of

      Recruiting
      • Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
      • 6-month course of antiandrogen drugs
      • Long-term course of antiandrogen drugs
      • Nanjing, Jiangsu, China
        Urology dpt, First Affiliated Hospital of Nanjing Medical Univer
      Jul 13, 2023

      Pancreatic Cancer, Hepatocellular Cancer, Biliary Tract Cancer Trial in Edmonton (Durvalumab, Gemcitabine, Nab paclitaxel)

      Not yet recruiting
      • Pancreatic Cancer
      • +3 more
      • Durvalumab
      • +5 more
      • Edmonton, Alberta, Canada
        Cross Cancer Institute
      Feb 1, 2023

      Gastric Cancer, Chemo Effect, Immune Checkpoint Inhibitor Trial in Shanghai (Sintilimab, paclitaxel-albumin, oxaliplatin, 5-FU)

      Recruiting
      • Gastric Cancer
      • +2 more
      • Sintilimab, paclitaxel-albumin, oxaliplatin, 5-FU
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Aug 1, 2023

      Hepatocellular Carcinoma, Portal Vein Thrombosis Trial in Seoul (PBT and atezolizumab/bevacizumab)

      Recruiting
      • Hepatocellular Carcinoma
      • Portal Vein Thrombosis
      • PBT and atezolizumab/bevacizumab
      • Seoul, Korea, Republic of
        Samsung Medical Center
      Nov 15, 2022

      Advanced Mucosal Melanoma Trial (Envafolimab combined with recombinant human endostatin and first-line chemo)

      Not yet recruiting
      • Advanced Mucosal Melanoma
      • Envafolimab combined with recombinant human endostatin and first-line chemotherapy
      • (no location specified)
      Sep 15, 2023

      Progression of Early Atrophic Lesions

      Not yet recruiting
      • Age-Related Macular Degeneration
      • No intervention
      • Salt Lake City, Utah
        University of Utah
      Jul 26, 2023

      Liquid Biopsy in High-grade Gliomas and Meningiomas

      Recruiting
      • High Grade Glioma
      • High Grade Meningioma
        • Milano, MI, Italy
        • +4 more
        Nov 29, 2022